fda ruling glp 1 Despite ruling, compounded GLP-1s are still giving Novo and Lilly headaches on the market GLP-1 medications and peptide therapies

Polycystic Ovary Syndrome: Update on Diagnosis and Treatment

Br J Dermatol 2008 Jul;159(1):35-48 Available from: Albert MR, Weinstock MA

Nutritional Medicine

GLP-1 medications are approved for adults who have a body mass index (BMI) of 30 or higher, or a BMI of at least 27 plus a weight-related medical condition, such as the following: Type 2 diabetes High blood pressure High cholesterol Obstructive sleep apnea Cardiovascular disease that increases the risk of heart attack or stroke MASH, or metabolic dysfunctionassociated steatohepatitis, a form of liver inflammation Avlin Imaeda, MD, PhD, a Yale Medicine gastroenterologist who is board-certified in obesity medicine, notes that qualifying for the medication based on heart disease aloneoften necessary for insurance coveragecan be challenging

: , BPC-157